eMedicine Specialties > Neurosurgery > Trauma

Hydrocephalus: Treatment

Author: Herbert H Engelhard III, MD, PhD, Director, UIC Neuro-Oncology Program, Chief, Division of Neuro-Oncology, Associate Professor, Department of Neurosurgery, University of Illinois at Chicago
Coauthor(s): Kamran Sahrakar, MD, Clinical Professor, Department of Neurosurgery, University of California-Davis; Dachling Pang, MD, FRCS(C), FACS, Clinical Professor of Neurosurgery, Chief of Pediatric Neurosurgery, University of California Davis School of Medicine; Chief, Regional Center for Pediatric Neurosurgery, Kaiser Permanente Hospitals of Northern California
Contributor Information and Disclosures

Updated: Dec 19, 2007

Treatment

Medical Therapy

Medical therapy is usually a temporizing measure. In transient conditions, such as sinus occlusion, meningitis, or neonatal intraventricular hemorrhage, medical therapy can be effective.

  • Acetazolamide (25 mg/kg/d in 3 doses): Careful monitoring of respiratory status and electrolytes is crucial. Treatment beyond 6 months is not recommended.
  • Furosemide (1 mg/kg/d in 3 doses): Again, electrolyte balance and fluid balance need to be monitored carefully.
  • Lumbar punctures: In neonates recovering from intraventricular hemorrhage, serial lumbar punctures can, in some cases, resolve hydrocephalus. If possible, this is the preferred method of treatment.
  • Removal of the underlying cause usually resolves hydrocephalus.

Surgical Therapy

As performance of cerebrospinal fluid (CSF) diversion (most often ventriculoperitoneal shunting) has increased in frequency, so has awareness of the pitfalls of the procedure. Recently, a resurgence of interest in third ventriculostomies has occurred.

Preoperative Details

Make every effort to identify the cause of hydrocephalus prior to considering a diversion procedure.

Do not consider an indwelling distal catheter in patients with active infection or high cerebrospinal fluid protein (>150 mg/dL).

Obtain some idea of brain compliance in order to select the optimum valve pressure and decide if the pressure-programmable valve should be used.

Use one dose of preoperative prophylactic antibiotics.

Intraoperative Details

  • Third ventriculostomy: Reserve this procedure for obstructive cases in patients who have normal or near-normal spinal fluid absorptive capacity. Use a blunt instrument to penetrate the floor of the third ventricle. Sharp instruments or lasers can cause vascular injury. Leaving a clamped drain in place postoperatively might be prudent. The burr hole placed on the coronal suture allows a straight trajectory to the foramen of Monro. Stereotactic guidance is not needed if endoscopic techniques are used.
  • Ventriculoperitoneal shunting: This procedure is by far the most common procedure for CSF diversion. The abdomen should be able to absorb the excess spinal fluid. Either 1 of 2 major locations for the burr holes are typically used. The ventricular catheter can be placed more reliably from the (right) frontal approach. Some surgeons still prefer parietooccipital catheters. The proximal catheter tip should lie anterior to the choroid plexus in the frontal horn of the lateral ventricle when the parietooccipital approach is used. Certain landmarks and measurements are used, as per neurosurgical texts. In difficult cases, stereotactic placement may be an option.
  • Ventriculoatrial shunting: This procedure is usually the first choice for patients who are unable to have distal abdominal catheters (eg, multiple operations, recent abdominal sepsis, known malabsorptive peritoneal cavity, abdominal pseudocyst1 ). The procedure carries more risk. Long-term complications are more serious (eg, renal failure, great vein thrombosis). Fluoroscopic guidance is necessary to prevent catheter thrombosis (short distal catheter) or cardiac arrhythmias (long distal catheter).
  • Ventriculopleural shunting: Reserve this procedure for patients with failed peritoneal and atrial shunts.
  • Torkildsen shunts or internal shunts are straight tubes that communicate to cerebrospinal fluid spaces without a valve. Their effectiveness and long-term efficacy are not proven.
  • Lumboperitoneal shunts are used in communicating hydrocephalus, especially if ventricles are small. Pseudotumor cerebri is the classical indication of this method of shunting. A positional valve is helpful because it turns off the flow of CSF when the patient is upright, thereby preventing overdrainage headache.

Postoperative Details

ICU observation after third ventriculostomy is advised.

In patients with high brain compliance, gradual assumption of the upright position and slow mobilization may reduce the incidence of early subdural hematoma formation.

Plain radiographs of the entire hardware system confirm good position and serve as excellent baseline studies for the future. Postoperative CT scan is used to document ventricular size (see Follow-up section).

Wounds should remain dry for at least 3 days postoperatively, until epithelialization has occurred.

In patients with pleural shunts, perform an early postoperative chest radiograph to ensure adequate absorption of fluid. Large effusions can occur in short periods, and respiratory problems can ensue.

Follow-up

  • Remove stitches by 2 weeks postsurgery.
  • Perform CT scan for baseline at 2-4 weeks postsurgery.
  • Monitor all children with shunts every 6-12 months. Carefully monitor head growth in infants. Check distal tubing length with plain radiographs when the child grows. Appropriate specialists should carefully assess child development.
  • What happens to ventricular size in patients who have a third ventriculostomy or Torkildsen shunt is not known. Other methods of assessment of patency need to be used, such as MRI flow studies and clinical evaluations (eg, detailed funduscopic examinations).
  • In patients with pseudotumor cerebri, visual acuity and fields should be monitored by the appropriate specialist.

Complications

The most common complications differ depending on the type of shunt and the underlying pathophysiology.

Infection is the most feared complication in the young age group. The overwhelming majority of infections occur within 6 months of the original procedure. Common infections are staphylococcal and propionibacterial. Early infections occur more frequently in neonates and are associated with more virulent bacteria such as Escherichia coli. Infected shunts need to be removed, the cerebrospinal fluid (CSF) needs to be sterilized, and a new shunt needs to be placed. Treatment of infected shunts with antibiotics alone is not recommended because bacteria can be suppressed for extended periods and resurface when antibiotics are stopped.

Subdural hematomas occur almost exclusively in adults and children with completed head growth. Incidence of subdural hematomas can be reduced by slow postoperative mobilization and perhaps by avoiding rapid intraoperative ventricular decompression. This allows for brain compliance reduction. The treatment is drainage and may require temporary occlusion of the shunt.

Shunt failure is mostly due to suboptimal proximal catheter placement. Occasionally, distal catheters fail. Suspect infection if the distal catheter is obstructed with debris. Abdominal pseudocysts are synonymous with low-grade shunt infection.

Overdrainage is more common in lumboperitoneal shunts and manifests with headaches in the upright position. In most cases, overdrainage is a self-limiting process. However, revision to a higher-pressure valve or a different shunt system occasionally may be necessary. A positional valve that closes when the patient is upright is also available.

Slit ventricle syndrome is an extremely rare condition in which brain compliance is unusually low. It mostly occurs in the setting of prior ventriculitis or shunt infection. The patient may develop high pressures without ventricular dilatation. The slit ventricle syndrome does not imply overdrainage, and the symptoms usually are those of high pressure rather than low pressure. Most experts also agree that slit ventricles predispose the patient to a higher incidence of ventricular catheter failure. Repeated ventricular blockage by the coapted ventricular wall may be helped by performing a subtemporal decompression that creates an artificial pressure reservoir and induces slight reenlargement of the slit ventricle.

More on Hydrocephalus

Overview: Hydrocephalus
Workup: Hydrocephalus
Treatment: Hydrocephalus
Follow-up: Hydrocephalus
References

References

  1. Hahn YS, Engelhard H, McLone DG. Abdominal CSF pseudocyst. Clinical features and surgical management. Pediatr Neurosci. 1985-1986;12(2):75-9. [Medline].

  2. Aronyk KE. The history and classification of hydrocephalus. Neurosurg Clin N Am. Oct 1993;4(4):599-609. [Medline].

  3. Black PMcL, Ojemann RG. Hydrocephalus in adults. In: Youman JR, ed. Neurological Surgery. 3rd ed. Philadelphia, Pa:. WB Saunders Co;1990:927-944.

  4. Gleason PL, Black PM, Matsumae M. The neurobiology of normal pressure hydrocephalus. Neurosurg Clin N Am. Oct 1993;4(4):667-75. [Medline].

  5. McLone DG, Partington MD. Arrest and compensation of hydrocephalus. Neurosurg Clin N Am. Oct 1993;4(4):621-4. [Medline].

  6. Milhorat T. Hydrocephalus: Pathophysiology and Clinical Features. Neurosurgery. 1996;3:3625-3632.

  7. Pang D, Altschuler E. Low-pressure hydrocephalic state and viscoelastic alterations in the brain. Neurosurgery. Oct 1994;35(4):643-55; discussion 655-6. [Medline].

  8. Sainte-Rose C. Hydrocephalus in childhood.In: Youmans JR, ed. Neurological Surgery. Philadelphia, Pa:. WB Saunders Co;1996:890-926.

Further Reading

Keywords

hydrocephalus, abnormal rise in cerebrospinal fluid volume, abnormal rise in cerebrospinal fluid pressure, CSF, imbalance of cerebrospinal fluid production and absorption, spinal bifida, congenital hydrocephalus, acquired hydrocephalus, aqueductal stenosis, intracranial tumor obstruction, intracranial trauma, intracranial hemorrhage, intracranial infection, disorders of cerebrospinal fluid production, disorders of cerebrospinal fluid circulation, disorders of cerebrospinal fluid absorption, cerebrospinal fluid diversion, third ventriculostomy, normal pressure hydrocephalus

Contributor Information and Disclosures

Author

Herbert H Engelhard III, MD, PhD, Director, UIC Neuro-Oncology Program, Chief, Division of Neuro-Oncology, Associate Professor, Department of Neurosurgery, University of Illinois at Chicago
Herbert H Engelhard III, MD, PhD is a member of the following medical societies: American Association for Cancer Research, American Association of Neurological Surgeons, American College of Surgeons, American Medical Association, American Society for Cell Biology, American Society of Clinical Oncology, Chicago Medical Society, Congress of Neurological Surgeons, Illinois State Medical Society, Society for Neuro-Oncology, and Society for Neuroscience
Disclosure: Nothing to disclose.

Coauthor(s)

Kamran Sahrakar, MD, Clinical Professor, Department of Neurosurgery, University of California-Davis
Kamran Sahrakar, MD is a member of the following medical societies: Alpha Omega Alpha, American Association of Neurological Surgeons, American Medical Association, California Medical Association, Florida Medical Association, and Nevada State Medical Association
Disclosure: Nothing to disclose.

Dachling Pang, MD, FRCS(C), FACS, Clinical Professor of Neurosurgery, Chief of Pediatric Neurosurgery, University of California Davis School of Medicine; Chief, Regional Center for Pediatric Neurosurgery, Kaiser Permanente Hospitals of Northern California
Dachling Pang, MD, FRCS(C), FACS is a member of the following medical societies: Alpha Omega Alpha, American Association of Neurological Surgeons, American College of Surgeons, Congress of Neurological Surgeons, Ontario Medical Association, and Royal College of Physicians and Surgeons of Canada
Disclosure: Nothing to disclose.

Medical Editor

Duc Hoang Duong, MD, Associate Professor, Director of Neuroscience Physician Assistant Program, Departments of Neurological Surgery and Neuroscience, Epilepsy Center, Charles R Drew University
Duc Hoang Duong, MD is a member of the following medical societies: American Neurological Association and North American Skull Base Society
Disclosure: Nothing to disclose.

Pharmacy Editor

Francisco Talavera, PharmD, PhD, Senior Pharmacy Editor, eMedicine
Disclosure: Nothing to disclose.

Managing Editor

Ryszard M Pluta, MD, PhD, Associate Professor, Neurosurgical Department Medical Research Center, Polish Academy of Sciences at Warsaw, Poland; Senior Researcher, Surgical Neurology Branch, National Institute of Neurological Disorders and Stroke, NIH
Disclosure: Nothing to disclose.

CME Editor

Herbert H Engelhard III, MD, PhD, Director, UIC Neuro-Oncology Program, Chief, Division of Neuro-Oncology, Associate Professor, Department of Neurosurgery, University of Illinois at Chicago
Herbert H Engelhard III, MD, PhD is a member of the following medical societies: American Association for Cancer Research, American Association of Neurological Surgeons, American College of Surgeons, American Medical Association, American Society for Cell Biology, American Society of Clinical Oncology, Chicago Medical Society, Congress of Neurological Surgeons, Illinois State Medical Society, Society for Neuro-Oncology, and Society for Neuroscience
Disclosure: Nothing to disclose.

Chief Editor

Allen R Wyler, MD, Medical Director, Northstar Neuroscience, Inc
Allen R Wyler, MD is a member of the following medical societies: American Academy of Neurological and Orthopaedic Surgeons, American Association of Neurological Surgeons, and Society of Neurological Surgeons
Disclosure: Nothing to disclose.

 
 
HONcode

We subscribe to the
HONcode principles of the
Health On the Net Foundation

All material on this website is protected by copyright, Copyright© 1994- by Medscape.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.